|
⚲
|
| CytomX Therapeutics LLC | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001465584 |
| Sale | 2009-06-01 ($2.5 M Offered, $2.5 M Sold) |
| Fund | |
| Phone | 8059649700 |
| Address | 460 Ward Drive, Ste E1 Santa Barbara, 93111 |
| Source | [EDGAR] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2026 |
|---|---|
| Nancy Stagliano | |
| Michael Pfau |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
RCG Special Opportunities Fund, Ltd
✚
|
0.0 | |
|
Squier-Dow Mae
✚
|
0.0 | |
|
Squires Wayne
✚
|
0.0 | |
|
Atherton, Inc.
✚
|
0.0 | |
|
ATHOS Crypto Launch Fund, LP
✚
|
0.0 | |
|
ATHOS Growth Fund II, LP
✚
|
0.0 | |
|
ATHOS Opportunity Fund PUR, LLC
✚
|
0.0 | |
|
Bedford Bancorp
✚
|
0.0 | |
|
5210 Fountaingate Investors LLC
✚
|
0.0 | |
|
RCG Renergys, LLC
✚
|
0.0 |